We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
AUM
$88.1M
AUM Growth
-$12.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRZN icon
1
Surrozen
SRZN
$282M
$49.7M 56.46%
1,916,950
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.44B
$38.3M 43.53%
3,540,777
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$8.62K 0.01%
46

Similar funds

Column Group's Q2 2026 Portfolio in Review

As of Q2 2026, Column Group held 3 positions worth $88.1M, down 13% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's ten largest holdings make up 100% of its $88.1M portfolio in Q2 2026.
  • Column Group opened 0 new positions and closed 0 in Q2 2026.
  • Column Group's portfolio value fell 13% quarter-over-quarter to $88.1M.

Based on Column Group's 13F filing for Q2 2026, filed 14 Aug 2026.